This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Hagit Krug: Innovator in Chemotherapy-Induced Neuropathy Therapy
Introduction
Hagit Krug is a notable inventor based in Bar Yam, Israel. He has made significant contributions to the field of medical research, particularly in the area of chemotherapy-induced peripheral neuropathy. His innovative work has the potential to improve the quality of life for patients undergoing chemotherapy.
Latest Patents
Hagit Krug holds a patent for an IL6R/IL6 chimera aimed at treating chemotherapy-induced peripheral neuropathy. This invention relates to the use of IL-6R/IL-6 chimera in alleviating the symptoms associated with chemotherapy-induced neuropathy. His patent represents a crucial advancement in therapeutic options for affected patients.
Career Highlights
Krug is associated with Yeda Research and Development Company Ltd., where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on patient care and treatment methodologies.
Collaborations
Hagit Krug has collaborated with esteemed colleagues, including Michel Revel and Judith Chebath. These partnerships have fostered an environment of innovation and shared expertise in the field of medical research.
Conclusion
Hagit Krug's contributions to the treatment of chemotherapy-induced peripheral neuropathy highlight his role as a significant inventor in the medical field. His work not only advances scientific understanding but also offers hope for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile